How much does a box of neratinib/neratinib cost?

Neratinib/neratinib (Neratinib) is an irreversible pan-ErbB tyrosine kinase inhibitor, mainly used to treat patients with HER2-positive breast cancer, especially in the "extended adjuvant treatment" stage after completion of HER2-targeted therapy such as trastuzumab. By continuously inhibiting the HER2 signaling pathway, the drug helps reduce the risk of recurrence and improve long-term disease-free survival. Different from traditional anti-HER2 treatment, neratinib has the advantage of oral administration and daily administration, and is suitable for continuous use after discharge, especially among patients whose breast cancer has entered a relative remission period but still has minimal residual disease.

In addition, neratinib is also used in combination with capecitabine to treat patients with HER2-positive advanced or metastatic breast cancer, especially for patients who have received two or more anti-HER2 therapies in the past. Because of this, it is recommended as a part of HER2-targeted therapy in clinical guidelines in many countries around the world.

Regarding the price of neratinib, its original drug is currently on the market in China and has been included in the Class B reimbursement scope of the national medical insurance catalog. Medical insurance reimbursement usually only covers specific groups of people, such as patients diagnosed with HER2-positive breast cancer and those who have completed standard adjuvant treatment and other specific conditions. The drug specifications are generally 40 mg and 180 tablets/box. The price of each box before reimbursement is about RMB 20,000. After reimbursement, depending on regional policies, the patient's out-of-pocket expenses will be significantly reduced.

In overseas markets such as the United States, the price of neratinib is relatively high. The price of each box of medicines of the same specifications often exceeds US$10,000, which puts considerable financial pressure on patients. It is worth noting that some countries and regions have already launched generic drugs. For example, the generic version of neratinib produced by Yaopin International Pharmaceutical Factory in Bangladesh has the same ingredients as the original drug and the same specifications of 40mg 180 tablets, but the price is more affordable, about more than 2,000 yuan, which may fluctuate depending on the exchange rate and channels.

Reference materials:https://en.wikipedia.org/wiki/Neratinib